{"id":"NCT04683627","sponsor":"Noven Pharmaceuticals, Inc.","briefTitle":"A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee","officialTitle":"A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-12-29","primaryCompletion":"2022-07-18","completion":"2022-07-25","firstPosted":"2020-12-24","resultsPosted":"2025-09-04","lastUpdate":"2025-09-04"},"enrollment":370,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis Pain of the Knee"],"interventions":[{"type":"DRUG","name":"Diclofenac sodium active topical patch","otherNames":["HP-5000"]},{"type":"DRUG","name":"Placebo patch","otherNames":["Placebo"]}],"arms":[{"label":"HP-5000 Treatment","type":"EXPERIMENTAL"},{"label":"Placebo Treatment","type":"PLACEBO_COMPARATOR"}],"summary":"A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) Pain of the Knee","primaryOutcome":{"measure":"Change From Baseline to Week 12 in WOMAC Pain Score (Intent-to-treat Set)","timeFrame":"Baseline and 12-week","effectByArm":[{"arm":"HP-5000 Treatment","deltaMin":-4.6,"sd":0.26},{"arm":"Placebo Treatment","deltaMin":-5.4,"sd":0.26}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":184},"commonTop":["Covid-19","osteoarthritis","Urinary tract Infection","Sinus bradycardia","Pain in extremity"]}}